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Abstract 19 
Background  20 
Recruiting patients for research in primary care is difficult in diseases that tend to 21 
remain underdiagnosed like chronic obstructive lung disease (COPD). Researchers 22 
may consider introducing case finding in patient recruitment but the impact on 23 
recruitment yield is largely unknown. 24 
Objectives 25 
To assess the impact of case finding on recruitment yield and population 26 
characteristics in primary care based COPD research. 27 
Methods 28 
For a cluster RCT on COPD in primary care, an opportunistic case finding strategy 29 
was introduced in patient recruitment in addition to recruiting patients with previously 30 
diagnosed COPD. Recruitment process and performance of primary care physicians 31 
(PCPs) was analysed. Numbers and characteristics of patients identified by case 32 
finding were compared with those of patients with previously diagnosed COPD. 33 
Results 34 
Thirty-five PCPs approached 398 and successfully recruited 216 patients during one 35 
year. The mean number of patients recruited was 6.3 (range 0 to 16) patients per 36 
PCP. Case finding contributed 71 (32.9%) patients with significantly milder disease 37 
with FEV1 % +16.7 (95%CI: +11.3 to +22.0), CAT difference -4 points (95%CI: -2 to -38 
6, p=<0.001), and less exacerbations resulting in a higher rate of GOLD class A (86.6 39 
% vs. 53.3%, p=<0.001). Smoking rate was significantly higher in patients with newly 40 
diagnosed COPD (70.4% vs. 48.6%; p=0.002). 41 
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Conclusion 42 
Case finding increased the number of recruited patients by 50%. The COPD patients 43 
identified by case finding differed importantly from those with previously diagnosed 44 
COPD. Researchers should be aware of COPD underdiagnosis and the potential 45 
impact of case finding during patient recruitment. 46 
 47 
 48 
  49 
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Introduction 50 
Research in primary care is complicated by a number of well recognized 51 
factors. Prevalence of individual disease for example is low and even the most 52 
common chronic conditions account only for a small minority of the reasons for 53 
encounter[1]. Consecutively, compared to specialized settings, only small proportions 54 
of patients are eligible for studies on specific diseases. Therefore, researchers need 55 
to allow for comparably long recruitment periods or need to bring together large 56 
numbers of primary care physicians (PCPs) volunteering in study participation to 57 
achieve sufficient patient recruitment. Unfortunately, trials in primary care most often 58 
fail to achieve intended recruitment goals or need to be prolonged substantially [2]. 59 
Moreover, PCPs themselves are difficult to motivate for study participation. Time 60 
constraints, low interest in research in general and increasing regulatory and 61 
administrative requirements are often mentioned important barriers for PCPs in this 62 
context [3-11]. 63 
Strategies supporting recruitment of patients and/or physicians for research 64 
projects in primary care have been developed and assembled [12].  Still, data on 65 
effectiveness of these strategies is limited and recruiting remains an unpredictable 66 
but critical stage in primary care based research [13, 14]. To facilitate patient 67 
recruitment, electronic medical records can be used and such strategies will become 68 
increasingly feasible with their ongoing implementation also in primary care. Such 69 
records, however, logically can only identify patients with previously diagnosed 70 
diseases. Therefore, such a sampling method may be unreliable in diseases that 71 
tend to be underdiagnosed in the healthcare setting harbouring the research project. 72 
Chronic obstructive pulmonary disease (COPD) is of unquestioned 73 
epidemiologic importance given its high and increasing prevalence, socioeconomic 74 
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burden and loss in quality of life in affected patients [15, 16]. Despite the fact that the 75 
majority of patients with COPD are treated in primary care, clinical research 76 
concentrates on secondary or tertiary care for COPD leaving the majority of the 77 
affected population underrepresented in trials [17-19]. Moreover, commonly used 78 
selection criteria for COPD trials admit only a minority of the affected population and 79 
representativeness for the “real life” COPD patients has been further questioned [20]. 80 
Research in primary care is needed to answer the question of external validity 81 
of trials conducted on COPD in specialized settings. However, COPD is known to be 82 
widely underdiagnosed in primary care, bringing up a further obstacle to COPD 83 
research in this important healthcare setting[21, 22]. To address the issue of COPD 84 
underdiagnosis several case finding strategies have been proposed and 85 
opportunistic strategies (focusing on the at-risk population during a routine practice 86 
visit) are thought to be efficient [23].  87 
In this study we describe the recruitment process of a cluster randomized trial 88 
on COPD in primary care where a case finding strategy has been implemented. The 89 
aim of the study was to assess recruiting performance, the contribution of case 90 
finding on the total number of recruited patients and also to compare characteristics 91 
of the sub-populations with COPD identified by case finding versus previously 92 
diagnosed COPD. 93 
Methods 94 
Study design, setting, registration and ethics statement 95 
This observational study was produced with data collected during the 96 
recruitment process and with baseline data from the Improving Care in Chronic 97 
Obstructive Lung Disease (CAROL) Study. It is a cluster-randomized multi centred 98 
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trial conducted in primary care practices located in the two largest cities of the 99 
Canton of Zurich Switzerland. The trial has been registered at ClinicalTrials.gov 100 
(NCT01921556) and the trial’s study protocol has been published [24]. In brief, the 101 
trial’s intervention aimed at improving chronic care for COPD patients in primary care. 102 
The intervention was based on the Chronic Care Model and consists in a 103 
multifaceted training for PCPs and their practice assistants in COPD care [25]. Local 104 
ethics committee approved the study (ethics committee of the Canton of Zurich, 105 
reference number KEK-ZH 2013-0189), informed consent was retrieved from all 106 
participating subjects and the study was conducted according to tenets of the 107 
declaration of Helsinki and good clinical practice guidelines. 108 
Recruitment of primary care physicians 109 
According to the trial’s power-calculation our goal was to recruit at least 30 110 
PCPs (each recruiting eight to ten patients). About 1300 PCPs practicing in the trial’s 111 
locations were sent a formal letter from our institute and the cantonal Department of 112 
Health in July 2013. Additionally, the study was presented at peer group meetings of 113 
regional PCPs’ networks. All PCPs were given a brief description of the study 114 
including study aim and eligibility criteria and a prominent description of requirements 115 
and benefits of study participation (incentives were 50 Swiss Francs per recruited 116 
patient and 200 Swiss Francs compensation for those randomized to the intervention 117 
group involving participation at the teaching sessions). Interested PCPs and their 118 
practice assistants were invited at kick-off meetings where complete background 119 
information and study aims were presented. After the kick-off meetings, we enrolled 120 
35 PCPs and their practice assistants, who all completed a training in how to conduct 121 
and interpret a spirometry according to international standards[26].  122 
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Case finding strategy and implementation of patient recruitment  123 
We chose our case finding strategy to be the opportunistic approach of 124 
consecutive patients in routine practice visits aged at least 45 years, who were 125 
smokers or ex-smokers with at least 10 pack-years (PY). With this feasible strategy 126 
we expected to newly detect COPD in at least 20% of the approached 127 
individuals[27]. In addition to the criteria from case finding, inclusion criteria for 128 
participating in the CAROL study were: available informed consent and diagnosis or 129 
confirmation airflow obstruction (FEV1/FVC < 0.7) in spirometry. Exclusion criteria 130 
were: visiting the practice for emergency purposes only, insufficient German 131 
language skills, asthma or hay fever or a co-occurring disease with an estimated life 132 
expectancy of less than six months. The case finding strategy and the following 133 
recruitment process were instructed and exemplified in a teaching session after the 134 
spirometry training. PCPs entered the patient recruitment period after completion of 135 
the training. 136 
The patient recruitment period started in December 2013 (after PCPs had 137 
completed spirometry training) and ended in January 2014. To support recruitment in 138 
practices we followed recommended principles of minimal administrative complexity 139 
and disruption, giving feedback (monthly email to PCPCs with benchmarking 140 
recruitment performance and three weekly outreach calls to practice assistants) and 141 
placing reminders on desks in practices [12]. Furthermore we supported PCPs in the 142 
interpretation of specific spirometry results if needed. 143 
Measures and data collection 144 
PCPs completed a questionnaire about themselves at their own enrolment in 145 
the study. The questionnaire comprised socio-demographic questions, questions 146 
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about medical specialization, full or part-time working, practice organization and the 147 
estimated number of patient contacts each day. 148 
For each recruited patient, the following set of data was collected by the PCP: 149 
timing of COPD diagnosis (identified by case finding or previously), spirometry 150 
results, dyspnoea according to modified British Medical Research Council Dyspnoea 151 
Scale (mMRC) [28], comorbidities, smoking status, COPD medication and health 152 
service utilization because of COPD. 153 
 The patient questionnaire was self-administered and piloted with six COPD 154 
patients in order to improve comprehensibility. The following set of data was 155 
collected: sociodemographic information, smoking habits and attitudes, COPD 156 
management recommendations and therapies received from the PCP during the last 157 
year (i.e. process indicators, primary endpoint of the CAROL trial), current COPD 158 
symptoms, exacerbations during previous year, actions taken if exacerbations 159 
occurred including health service utilization and the COPD assessment test (CAT) 160 
[29]. PCPs and the patients received pre-stamped envelopes for sending the 161 
completed questionnaires directly to the study centre. PCPs and patients had no 162 
access to each other’s answers. 163 
Outcomes 164 
Outcomes for this study were: 1) PCP recruiting performance, 2) the 165 
contribution of case finding to the total number of patients recruited, 3) characteristics 166 
of recruited patients and differences between the COPD patients identified by case 167 
finding and those with previously diagnosed COPD. 168 
Statistical analysis 169 
We report counts and proportions for categorical data as well as means and 170 
standard deviations (SD) or medians and interquartile ranges (IQR) as appropriate. 171 
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We compared groups applying bivariate statistics using T-test or Wilcoxon rank sum 172 
test for continuous data and Chi-squared test or Fisher’s exact test for nominal data 173 
and report p-values or 95% confidence intervals (95% CI) when appropriate. The 174 
minimum clinically important difference in the COPD assessment test (CAT) has 175 
been defined as two points [30]. Missing values were inquired at the respondents and 176 
completed accordingly if available. 177 
Results 178 
Primary care physicians’ characteristics and recruiting performance 179 
Thirty-five PCPs from 21 different practices entered the patient recruiting period. 180 
Recruitment of these PCPs took nine months. PCPs’ median age was 49.7 (IQR 42.8 181 
to 58.3) years and 26 (74.3%) were male. 31 (88.6%) were working in group-182 
practices together with one to five colleagues (not necessarily participating in the 183 
study). Twenty-three (65.7%) were specialized in general medicine, 13 (37.1%) in 184 
internal medicine. Twenty-three (65.7%) of the PCPs reported to work full time, 60% 185 
was the lowest part-time assignment. On average, the PCPs estimated to see 24.6 186 
(SD: 5.9) patients on a typical working day. 187 
During the one-year patient recruiting period, each PCP approached on 188 
average 11.4 (SD: 8.6) patients, with considerable variability between the individual 189 
PCPs ranging from 0 to 31 patients. From a total of 398 eligible patients, 51 (12.8%) 190 
declined study participation or spirometry testing. From 147 consenting patients with 191 
previously diagnosed COPD, two were excluded because obstruction was not 192 
confirmed in spirometry. From 200 consenting patients who were identified by the 193 
case finding criteria, 71 (35.5%) had obstruction in spirometry. Therefore, from all 194 
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398 approached patients, PCPs recruited 216 (54.3%). The flowchart of the 195 
recruitment process is shown in Figure 1. 196 
Each PCP recruited 6.3 patients (SD: 4.5, range 0 to 16) on average. The 197 
maximum of recruited patients per month was reached in the 4th month after study 198 
begin, followed by a rapid decline with stabilization after 9 months. Recruiting 199 
performance over time is shown in Figure 2. 200 
Contribution of case finding to total number of patients recruited 201 
Among the 216 recruited patients, 145 (67.1%) had a previously diagnosed 202 
COPD and the median duration of illness was five (IQR 2 to 8) years. From 200 203 
patients who underwent spirometry without having a previous COPD diagnosis (case 204 
finding population), 71 had COPD. This corresponded to a 35.6% specificity of case 205 
finding in individuals without previously diagnosed COPD. These 71 individuals 206 
identified by case finding contributed 32.9% of the study population and case finding 207 
therefore increased the overall recruitment yield by 49.0%.  208 
Patient characteristics and subpopulation differences  209 
Overall, included patients were 68.1 (SD 9.7) years old on average and 59.5% 210 
male. Clinically most important differences between the subpopulation identified by 211 
case finding and those with previous COPD diagnosis appeared in the severity of 212 
airflow limitation reflected by FEV1 that resulted +16.7 (95%CI: +11.3 to +22.0) 213 
percentage points higher in the subpopulation identified by case finding. Also the 214 
between-group difference in the CAT summary score was clinically importantly 215 
different indicating milder symptoms and impairment in the subpopulation identified 216 
by case finding: between-group difference in medians of -4 (95%CI: -2 to -6) points. 217 
Moreover, a lower proportion of patients having ≥2 exacerbations or at least 1 218 
exacerbation with hospitalisation in the previous 12 months was noted in this 219 
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subpopulation (5.6% versus 23.4%, p=0.001). In terms of the updated GOLD 220 
guidelines [26] this translated to a significantly higher rate of GOLD classification A 221 
(86.6% versus 53.3%, p=<0.001)  in the subpopulation with case finding COPD 222 
diagnosis. Furthermore, the proportion of active smokers was higher in the 223 
subpopulation of case finding-identified COPD (70.4% compared to 48.6%, 224 
p=<0.002). Chronic comorbidities, were more common in the subpopulation with 225 
previous COPD diagnosis (mean number of chronic comorbidities 1.2 vs. 0.8, 226 
p=0.01). More detailed comparative patient characteristics are given in Table 1.227 
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Discussion 228 
Main findings 229 
Case finding substantially supported recruitment by contributing one out of three 230 
patients to the total study population. 231 
The population identified by case finding differed importantly from the population with 232 
previously diagnosed COPD and notably influenced important characteristics of the 233 
total population recruited. 234 
Interpretation of findings in relation to previously published work 235 
In population based studies, patients with undiagnosed COPD have been found 236 
to outnumber the patients with diagnosed COPD and also to have higher current 237 
smoking rates and have less severe limitation of airflow. Furthermore, an important 238 
variation between international healthcare systems was found with the proportion of 239 
undiagnosed versus diagnosed individuals ranging from 50% to 98%[21]. In primary 240 
care the proportions of undiagnosed COPD patients are similarly variable and 241 
undiagnosed individuals have consistently been shown to be less symptomatic [22, 242 
27, 31-34]. Results from our study are in line with previous epidemiological research 243 
as we identified a relevant proportion of patients with undiagnosed COPD in primary 244 
care in significantly earlier stages of the disease. Concerning case finding, we 245 
identified an undiagnosed case of COPD in every third patient falling under the 246 
predefined case finding criteria. This detection rate was above our expectations, 247 
however, our case finding criteria might have had higher specificity because of older 248 
age and additional minimum number of PYs than the criteria for opportunistic case 249 
finding recently described with a detection rate around 20% [23]. 250 
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The clinical importance of case finding and early detection of COPD consists in 251 
creating opportunities for early preventive interventions especially if modifiable risk 252 
factors can be targeted. In this context, smoking cessation is the intervention with 253 
highest beneficial impact on disease progression and specific recommendations to 254 
increase smoking cessation rates in COPD patients exist.[26, 35] In primary care, 255 
where most COPD patients are in early disease stages, the potential of preventive 256 
measures is highest. Here, in addition to clinical aspects, we describe important 257 
methodological implications to case finding in COPD research: Knowing about the 258 
difficulties to implement patient recruitment in primary care, researchers are naturally 259 
tempted to make use of electronic medical record searches to identify eligible cases. 260 
Such approaches are already followed and thought to produce representative patient 261 
samples [36, 37]. Without knowledge about COPD underdiagnosis in the studied 262 
population, however, such strategies are at risk to produce biased samples since 263 
they might miss large proportion of the population intended to represent. In our 264 
setting, an approach relying only on previously identified cases, would have most 265 
likely recruited a different population. Especially concerning is that the differences 266 
appeared in the most important prognostic variables namely airflow limitation and 267 
smoking status. Underdiagnosis of COPD can therefore be an important source of 268 
sampling bias by systematically occurring in milder diseased individuals. Since 269 
diagnostic performance for COPD is known to be setting-specific, recruitment 270 
methods drawing only from previously identified cases of COPD are likely to produce 271 
heterogeneous patient samples in different health care settings. Consecutively, 272 
populations are difficult to compare across studies and moreover still not represent 273 
the majority of the diseased population even if performed in primary care. 274 
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Strengths and limitations of the study 275 
To our knowledge, this is the first report emphasizing the implications of case 276 
finding for recruitment of COPD patients in primary care based research. This article 277 
describes the advantages of case finding for research purposes and contributes to 278 
research methodology in primary care and COPD. Furthermore, this is the first 279 
comprehensive report giving detailed insights into the recruitment strategy and 280 
recruitment outcomes of a primary care based cluster randomized study on COPD, 281 
thus supporting researchers embarking on similar research projects.  282 
The main limitation of this study is the observational design. We can only 283 
assume that patients with undiagnosed COPD would truly not have found access to 284 
our total study population without the introduction of case finding. We are, however, 285 
confident that no similarly relevant proportion of patients with undiagnosed COPD 286 
would have been identified. Furthermore, the recruitment of PCPs themselves proved 287 
to be difficult and progressed slowly. We must assume that the participating PCPs 288 
represent a comparably highly motivated sample with higher interest in either COPD, 289 
research per se or both. Therefore, implementation of case finding and also its yield 290 
may perform differently in non-research environments, however, in both clinical and 291 
research settings volunteer bias occurs. 292 
Implications for future research, policy and practice 293 
For future research on COPD in primary care we recommend that diagnostic 294 
performance should be at least measured by implementing a case finding protocol 295 
before relying on electronic medical record searches only. This is how the risk of bias 296 
from underdiagnosis and selective recruiting can at least be assessed if researchers 297 
were still to rely on electronic medical record based recruitment. Considering the 298 
specific case finding strategy, there is little consensus on which is best. In this study 299 
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the efforts of implementing an opportunistic case finding strategy were moderate and 300 
consisted in raising the awareness for the disease among PCPs and strengthening 301 
their diagnostic skills in spirometry testing. Opportunistic case finding is already 302 
considered to be needed in every day clinical practice and we believe that also 303 
COPD research in primary care would benefit from it. This, not only by supporting 304 
notoriously difficult recruitment processes but also by increasing representativeness 305 
and comparability of selected patient samples. 306 
Conclusions 307 
Opportunistic case finding increased the number of recruited patients by almost 308 
50%. The COPD patients identified by case finding differed importantly from those 309 
with previously diagnosed COPD. Researchers should be aware of the impact of 310 
case finding during recruitment, especially in healthcare settings with high rates of 311 
COPD underdiagnosis. 312 
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Tables 456 
Table 1 heading 457 
Characteristics of total study population (n=216) and comparison of 458 
characteristics of the subpopulations with previously identified COPD and those 459 
identified by case finding.460 
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variable  category (boundaries)  description 
Total population 
COPD 
previously 
diagnosed 
COPD 
identified by 
case finding 
p value 
previous vs. 
case finding 
identified 
COPD 
mean, 
median 
or n 
(SD), IQR 
or % 
mean, 
median 
or n 
(SD), IQR 
or % 
mean, 
median 
or n 
(SD), IQR 
or % 
Total n        216  100%  145   100%  71  100%   
Age  years  mean (SD)  68.1  (9.7)  69.96  (9.2)  64.32  (9.7)  <0.0011) 
Sex  male  n and %  128  59.5%  84  58.3%  44  62.0%  0.6092) 
BMI   kg/m2  mean (SD)  25.76  (5.34)  25.74  (5.6)  25.81  (4.9)  0.9241) 
GOLD Class 
GOLD A  n and %  131  64.2%  73  53.3%  58  86.6% 
<0.0013) GOLD B  n and %  38  18.6%  33  24.1%  5  7.5% GOLD C  n and %  11  5.4%  9  6.6%  2  3.0% 
GOLD D  n and %  24  11.8%  22  16.1%  2  3.0% 
Severity of airflow 
limitation by FEV1 % 
predicted 
mild (≥80%)  n and %  56  26.0%  25  17.4%  31  43.7% 
<0.0013) 
moderate (≥50 and <80%)  n and %  115  53.5%  78  54.2%  37  52.1% 
severe (≥30 and <50%)  n and %  37  17.2%  34  23.6%  3  4.2% 
very severe (<30%)  n and %  7  3.3%  7  4.9%  0  0.0% 
FEV1 % predicted     mean (SD)  66.06  (20.15)  60.55  (18.5)  77.23  (18.8)  <0.0011) 
CAT impact 
of disease 
low (<10 points)  n and %  80  42.6%  44  34.4%  36  60.0% 
0.0053) 
medium (10‐20 points)  n and %  89  47.3%  67  52.3%  22  36.7% 
high (21‐30 points)  n and %  17  9.0%  15  11.7%  2  3.3% 
very high (>30 points)  n and %  2  1.1%  2  1.6%  0  0.0% 
CAT summary score     median and IQR  11  7 to 16  12  8 to 18  8  5 to 12  <0.0014) 
mMRC 
0  n and %  51  24.1%  21  14.7%  30  43.5% 
<0.0013) 
1  n and %  91  42.9%  61  42.7%  30  43.5% 
2  n and %  50  23.6%  41  28.7%  9  13.0% 
3  n and %  16  7.5%  16  11.2%  0  0.0% 
4  n and %  4  1.9%  4  2.8%  0  0.0% 
Current smoking     n and %  120  55.6%  70  48.6%  50  70.4%  0.0022) 
Exacerbation at inclusion     n and %  33  17.3%  30  22.4%  3  5.3%  0.0043) 
Comorbidities 
diabetes  n and %  29  13.8%  23  16.3%  6  8.7%  0.1332) 
hypertension  n and %  112  53.1%  76  53.9%  36  51.4%  0.7352) 
coronary heart disease  n and %  37  17.7%  31  21.8%  6  9.0%  0.0232) 
congestive heart failure  n and %  20  9.5%  17  11.8%  3  4.5%  0.0913) 
22 
 
depression  n and %  41  19.8%  28  19.9%  13  19.7%  0.9782) 
1)Welch Two Sample t‐test, 2)Pearson's Chi‐squared test, 3)Fisher's Exact Test for Count Data, 4)Wilcoxon rank sum test 
461 
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Figure Legends 462 
Figure 1 463 
Flowchart of the study 464 
Figure 2 465 
Overall number of COPD patients (n=216) recruited per month by 35 PCPs. The 466 
light grey bars represent patients with previously diagnosed COPD, the dark-grey 467 
bars above represent patients COPD identified by case finding. 468 
